CSIMarket
 


Kewaunee Scientific Corporation  (KEQU)
Other Ticker:  
 


Kewaunee Scientific's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kewaunee Scientific's ROI in the fourth quarter of 2024?
Kewaunee Scientific Corporation achieved a return on average invested assets (ROI) of 21.98 % in its fourth quarter of 2024, this is above KEQU's average return on investment of 3.62%.
Kewaunee Scientific Corporation invested over the 12 months ending in its fourth quarter of 2024 $87 million

ROI has improved compared to 10.83% in the third quarter of 2024, due to net income growth.

Within the Healthcare sector 27 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Apr 30 2024 quarter, so far to 239, from total ROI ranking in the third quarter of 2024 at 730.

Definition and Formula of Return on Investment


Return On Investment (Apr 30 2024)
IV. Quarter
(Jan 31 2024)
III. Quarter
(Oct 31 2023)
II. Quarter
(Jul 31 2023)
I. Quarter
(Apr 30 2023)
IV. Quarter
Y / Y Investment Change 19.41 % 8.73 % 9.65 % 6.62 % -
Y / Y Net Income Change 921.85 % 130.69 % - - -
Investment (TTM) in Millions 95 85 84 82 80
Return On Investment (TTM) 21.98 % 10.83 % 9.29 % 5.79 % 1.74 %
KEQU's Overall Ranking # 239 # 730 # 836 # 1275 # 2086
Seq. Investment Change 11.72 % 1.35 % 3.16 % 2.22 % 1.73 %
Seq. Net Income Change 341.33 % -10.49 % 12.52 % 129.89 % -0.36 %
Net Income (TTM) in Millions 19 9 8 5 1




Return On Investment KEQU's Ranking
Within: No.
Industry # 1
Sector # 28
Overall # 239

Return On Investment Statistics
High Average Low
21.1 %
3.62 %
-15.14 %
(Apr 30 2024)   (Jan 31 2022)







Financial Statements
Kewaunee Scientific's IV. Quarter Investments $ 95 Millions KEQU's Balance sheet
Kewaunee Scientific's IV. Quarter Income $ 11 Millions Quarterly KEQU's Income Statement
KEQU's Income by Division See KEQU's Income by Division


KEQU Annual Return On Investment (Apr 30 2024)
2024
(Apr 30 2023)
2023
(Apr 30 2022)
2022
(Apr 30 2021)
2021
(Apr 30 2020)
2020
Total Investments in Millions 95 80 77 55 57
Y / Y Investment Growth 19.41 % 3.84 % 38.81 % -2.99 % 16.14 %
Net Income in Millions 19 1 -6 -4 -5
Y / Y Net Income Growth 1302.28 % - - - -
Annual Return On Investment 19.97 % 1.7 % -7.8 % -6.51 % -8.09 %


Annual Roi Comment
In the fiscal year 2024 ROI improved to 19.97 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KEQU's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for KEQU's Competitors
Roi for Kewaunee Scientific's Suppliers
Return On Investment for KEQU's Customers

Other Ratios
KEQU's Roa KEQU's Inventory Turnover Ratio KEQU's Growth Rates KEQU's Dividend Statistics
KEQU's Profitability Ratios KEQU's Asset Turnover Ratio KEQU's Dividend Growth
KEQU's Roe KEQU's Valuation Ratios KEQU's Financial Strength Ratios KEQU's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 30 2024, within Healthcare Sector ROI
Dariohealth Corp   52.42 %
Siga Technologies Inc  50.83 %
Mimedx Group Inc   45.65 %
Cardiff Lexington Corporation  43.02 %
Protagonist Therapeutics inc   42.60 %
Idexx Laboratories Inc  38.71 %
Elite Pharmaceuticals Inc   37.90 %
Medpace Holdings Inc   37.60 %
National Research Corporation  35.99 %
Earth Science Tech Inc   35.39 %
Mettler Toledo International Inc  34.94 %
Star Equity Holdings Inc   33.79 %
Lantheus Holdings Inc   32.97 %
Semler Scientific inc   30.36 %
Johnson and Johnson  29.92 %
Arcutis Biotherapeutics Inc   24.32 %
Kaya Holdings Inc  24.26 %
Corcept Therapeutics Inc  23.68 %
Iradimed Corporation  22.19 %
Vertex Pharmaceuticals Inc  21.60 %
Kewaunee Scientific Corporation  21.10 %
Harmony Biosciences Holdings inc   20.61 %
Chemed Corporation  19.96 %
Dr Reddy s Laboratories Limited  19.10 %
Zoetis Inc   19.09 %
Halozyme Therapeutics Inc   18.75 %
West Pharmaceutical Services Inc   18.21 %
Exelixis Inc   17.86 %
Entrada Therapeutics Inc   17.30 %
United Therapeutics Corporation  17.09 %


Date modified: 2024-06-29T12:19:21+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com